Home › Funds › AIGH Capital Management LLC › APRE

AIGH Capital Management LLC position in APRE

APREA THERAPEUTICS INC · Health Care

AIGH Capital Management LLC reported holding 1,015,541 shares of APRE (APREA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$762K, representing 0.08% of its reported portfolio and ranking #43 among its reported holdings. AIGH Capital Management LLC has disclosed APRE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.02M sh
Reported value held$761.66K
Portfolio Weight0.08%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AIGH Capital Management LLC's APRE position evolved

AIGH Capital Management LLC first disclosed a stake in APRE in Q3 2023 at 349,300 shares (US$1.5M). The position peaked in Q1 2024 at 539,300 shares, worth US$3.5M. Across 13 filings, AIGH Capital Management LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 1,015,541 shares valued at US$762K. Notable position changes include a 54% increase in Q1 2024 (shares fell 39% over the following quarter), a 31% trim in Q4 2025 (shares fell 11% over the following quarter), a 174% increase in Q1 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 349.30K $1.46M New
Q4 2023 349.30K $1.64M Hold
Q1 2024 539.30K $3.50M Add
Q2 2024 539.30K $2.19M Hold
Q3 2024 539.30K $1.48M Hold
Q4 2024 539.30K $1.77M Hold
Q1 2025 539.30K $1.10M Hold
Q2 2025 539.30K $912.99K Hold
Q3 2025 539.30K $795.47K Hold
Q4 2025 370.54K $316.07K Reduce
Q1 2026 1.02M $774.76K Add
Q2 2026 1.02M $814.77K Hold
Q3 2026 1.02M $761.66K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APRE and 13F data

APRE (APREA THERAPEUTICS INC) is a Health Care company. 22 other funds we track also report a position in APRE. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APRE

No other tracked fund reports a position in APRE.

All APRE fund holders →

FAQ

How long has AIGH Capital Management LLC held APRE?

AIGH Capital Management LLC has disclosed APRE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AIGH Capital Management LLC's current position in APRE?

As of Q3 2026, AIGH Capital Management LLC holds 1.02M shares of APRE (APREA THERAPEUTICS INC), valued at $761.66K, representing 0.08% of its reported portfolio and ranking #43.

Has AIGH Capital Management LLC been buying or selling APRE?

In the latest 13F filing (Q3 2026), AIGH Capital Management LLC held unchanged its position in APRE. The position peaked in Q1 2024 at 539.30K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.